Search - tctmd.com

Displaying 241 - 260 of 1143

Sort: Relevancy | Date

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Industry News

World's First Endovascular Neuromodulation Device Implanted in Man for the Treatment of Congestive Heart Failure

November 04, 2015

News Industry News

Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke

November 04, 2015

News Industry News

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

November 03, 2015

News Industry News

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

November 02, 2015

News Industry News

Avinger Successfully Completes VISION IDE Trial for Pantheris(TM)

November 02, 2015

News Daily News

Mechanical Circulatory Support Growing More Common During PCI

Todd Neale

October 29, 2015

News Opinion Fellow Talk

A Fellow’s Take on Technology: Looking Closer at the CardioMems and CardioHelp Devices

Sarah Elsayed, MD

October 28, 2015

News Daily News

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Caitlin E. Cox

October 28, 2015

News Industry News

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

October 27, 2015

News Industry News

AV Medical Technologies Ltd. Receives FDA Clearance for its Chameleon™ Angioplasty Balloon Catheter

October 27, 2015

News Industry News

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

October 27, 2015

News Industry News

Carnegie Mellon Researchers Hack Off-the-Shelf 3-D Printer Towards Rebuilding the Heart

October 26, 2015

News Industry News

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

October 20, 2015

Presentation TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

Presenter: Nabil Dib, Philippe Menasché, Angel Arenal

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

News Industry News

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

October 15, 2015

Advertisement

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

World's First Endovascular Neuromodulation Device Implanted in Man for the Treatment of Congestive Heart Failure

Neuravi Announces First Patient Treated in International Pivotal Clinical Trial of Novel Stent Retriever for Acute Ischemic Stroke

scPharmaceuticals Announces Positive Results from Pivotal Trial of its Novel Subcutaneous Furosemide Formulation in Patients with Heart Failure

First Patient Successfully Enrolled into ROADSTER 2 Transcarotid Artery Revascularization (TCAR) Study

Avinger Successfully Completes VISION IDE Trial for Pantheris(TM)

Mechanical Circulatory Support Growing More Common During PCI

A Fellow’s Take on Technology: Looking Closer at the CardioMems and CardioHelp Devices

ADAPT-DES Analysis Reopens Debate Over Possible PPI, Clopidogrel Interaction

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

AV Medical Technologies Ltd. Receives FDA Clearance for its Chameleon™ Angioplasty Balloon Catheter

Amgen and Cytokinetics Announce Positive Top-Line Results From COSMIC-HF, A Phase 2 Trial of Omecamtiv Mecarbil in Patients With Chronic Heart Failure

Carnegie Mellon Researchers Hack Off-the-Shelf 3-D Printer Towards Rebuilding the Heart

One-Year Outcomes From the COMBO REMEDEE All-Comers Registry Presented at TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Edwards SAPIEN 3 Valve Demonstrates High Survival And Low Stroke Rate At 1 Year

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content